As the proportion of GSC populations significantly correlated with tumor malignancy47, examining VDAC2 expression in glioma specimens is of great significant to predict the possibility of GSC phenotypic conversion from NSTCs thus indicates patient outcomes. This evidence concerns the gene VDAC2 and central nervous system cancer.